|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.46 EUR | -1.47% |
|
-9.56% | +128.03% |
| 07-17 | Frankfurt Stocks Close: DAX widens weekly loss on tech weakness | DP |
| 07-17 | Chip and AI stocks worldwide slide again | DP |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.67 | 7.81 | 9.79 | 8.04 | 6.48 | |||||
Return on Total Capital | 11.74 | 10.13 | 13.01 | 10.06 | 7.54 | |||||
Return On Equity % | 17.42 | 16.01 | 20.15 | 13.07 | 9.7 | |||||
Return on Common Equity | 17.59 | 16 | 20.16 | 13.08 | 9.7 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 42.32 | 42.16 | 44.3 | 41.45 | 39.95 | |||||
SG&A Margin | 8.09 | 8.73 | 7.41 | 7.27 | 8.71 | |||||
EBITDA Margin % | 25.84 | 23.78 | 25.57 | 22.72 | 21.86 | |||||
EBITA Margin % | 24.27 | 22.44 | 24.24 | 21.05 | 19.47 | |||||
EBIT Margin % | 24 | 22.18 | 24.03 | 20.8 | 19.17 | |||||
Income From Continuing Operations Margin % | 22.11 | 21.69 | 23.05 | 16.78 | 15.32 | |||||
Net Income Margin % | 22.3 | 21.68 | 23.05 | 16.79 | 15.31 | |||||
Net Avail. For Common Margin % | 22.3 | 21.68 | 23.05 | 16.79 | 15.31 | |||||
Normalized Net Income Margin | 15.35 | 14.29 | 15.19 | 12.97 | 11.22 | |||||
Levered Free Cash Flow Margin | 6.13 | -3.85 | -23.85 | -16.53 | 29.71 | |||||
Unlevered Free Cash Flow Margin | 6.18 | -3.8 | -23.83 | -16.49 | 29.8 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.64 | 0.56 | 0.65 | 0.62 | 0.54 | |||||
Fixed Assets Turnover | 6.24 | 5.35 | 5.11 | 3.38 | 2.37 | |||||
Receivables Turnover (Average Receivables) | 7.02 | 4.62 | 4.54 | 3.61 | 3.44 | |||||
Inventory Turnover (Average Inventory) | 2.48 | 1.56 | 1.14 | 0.97 | 1.02 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.05 | 3.02 | 3.12 | 4.12 | 5.61 | |||||
Quick Ratio | 3.16 | 2 | 1.44 | 1.7 | 3.11 | |||||
Operating Cash Flow to Current Liabilities | -0.1 | 0.16 | -0.19 | 0.16 | 1.71 | |||||
Days Sales Outstanding (Average Receivables) | 52.02 | 79.06 | 80.33 | 101.43 | 106.25 | |||||
Days Outstanding Inventory (Average Inventory) | 147.3 | 234.5 | 321.49 | 376.96 | 356.45 | |||||
Average Days Payable Outstanding | 19.22 | 32.32 | 36.33 | 48.55 | 49.47 | |||||
Cash Conversion Cycle (Average Days) | 180.1 | 281.24 | 365.5 | 429.85 | 413.22 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 0.72 | 1.22 | 0.72 | 0.64 | 0.51 | |||||
Total Debt / Total Capital | 0.72 | 1.2 | 0.72 | 0.64 | 0.51 | |||||
LT Debt/Equity | 0.56 | 0.9 | 0.51 | 0.41 | 0.32 | |||||
Long-Term Debt / Total Capital | 0.55 | 0.89 | 0.51 | 0.41 | 0.32 | |||||
Total Liabilities / Total Assets | 20.05 | 26.51 | 24.5 | 16.73 | 12.44 | |||||
EBIT / Interest Expense | 368.97 | 288.57 | 738.45 | 306.92 | 133.51 | |||||
EBITDA / Interest Expense | 401.29 | 313.48 | 795.09 | 340.09 | 154.45 | |||||
(EBITDA - Capex) / Interest Expense | 342.51 | 236.65 | 501.58 | 120.79 | 120.13 | |||||
Total Debt / EBITDA | 0.04 | 0.07 | 0.03 | 0.04 | 0.04 | |||||
Net Debt / EBITDA | -3.11 | -2.84 | -1.08 | -0.41 | -1.78 | |||||
Total Debt / (EBITDA - Capex) | 0.04 | 0.1 | 0.05 | 0.1 | 0.05 | |||||
Net Debt / (EBITDA - Capex) | -3.64 | -3.76 | -1.71 | -1.14 | -2.29 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 59.32 | 7.98 | 35.99 | 0.52 | -12.1 | |||||
Gross Profit, 1 Yr. Growth % | 67.63 | 7.57 | 42.89 | -5.94 | -15.28 | |||||
EBITDA, 1 Yr. Growth % | 170.24 | -0.66 | 45.93 | -10.7 | -15.42 | |||||
EBITA, 1 Yr. Growth % | 213.81 | -0.19 | 46.6 | -12.71 | -18.69 | |||||
EBIT, 1 Yr. Growth % | 219.22 | -0.2 | 47.03 | -13.02 | -18.98 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 175.13 | 5.94 | 44.51 | -26.82 | -19.76 | |||||
Net Income, 1 Yr. Growth % | 174.26 | 4.99 | 44.55 | -26.79 | -19.81 | |||||
Normalized Net Income, 1 Yr. Growth % | 225.7 | 0.52 | 44.19 | -14.18 | -23.9 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 174.19 | 4.71 | 44.94 | -27.13 | -19.61 | |||||
Accounts Receivable, 1 Yr. Growth % | 96.01 | 47.84 | 31.64 | 22.72 | -32.43 | |||||
Inventory, 1 Yr. Growth % | 52.53 | 85.36 | 76.42 | -6.42 | -23.17 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 16.61 | 33.73 | 49.27 | 53.58 | 6.59 | |||||
Total Assets, 1 Yr. Growth % | 25.45 | 21.86 | 14.11 | -1.12 | 2.1 | |||||
Tangible Book Value, 1 Yr. Growth % | 22.75 | 13.52 | 19.28 | 9.46 | 8.55 | |||||
Common Equity, 1 Yr. Growth % | 19.5 | 12.01 | 17.23 | 9.07 | 7.36 | |||||
Cash From Operations, 1 Yr. Growth % | -65.54 | -44.04 | -227.33 | -155.46 | 694.51 | |||||
Capital Expenditures, 1 Yr. Growth % | 109.01 | 66.91 | 119.97 | 56.36 | -70.85 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 11.86K | -167.83 | 749.73 | -30.31 | -257.95 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 9.19K | -166.54 | 759.82 | -30.43 | -258.83 | |||||
Dividend Per Share, 1 Yr. Growth % | 172.73 | 3.33 | 29.03 | -62.5 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 28.54 | 31.16 | 21.18 | 16.92 | -6 | |||||
Gross Profit, 2 Yr. CAGR % | 29.2 | 34.29 | 23.98 | 15.94 | -10.73 | |||||
EBITDA, 2 Yr. CAGR % | 56.44 | 63.85 | 20.53 | 14.16 | -13.09 | |||||
EBITA, 2 Yr. CAGR % | 66.93 | 76.98 | 21.1 | 13.12 | -15.76 | |||||
EBIT, 2 Yr. CAGR % | 68.31 | 78.48 | 21.27 | 13.08 | -16.05 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 70.88 | 70.73 | 23.73 | 2.83 | -23.37 | |||||
Net Income, 2 Yr. CAGR % | 70.69 | 69.69 | 23.2 | 2.87 | -23.38 | |||||
Normalized Net Income, 2 Yr. CAGR % | 64.59 | 80.94 | 20.52 | 11.24 | -19.19 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 71.2 | 69.44 | 23.19 | 2.77 | -23.46 | |||||
Accounts Receivable, 2 Yr. CAGR % | 66.5 | 70.23 | 39.51 | 27.1 | -8.94 | |||||
Inventory, 2 Yr. CAGR % | 23.55 | 68.14 | 80.83 | 28.49 | -15.21 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.09 | 24.88 | 41.29 | 51.41 | 27.95 | |||||
Total Assets, 2 Yr. CAGR % | 14.7 | 23.64 | 17.92 | 6.22 | 0.48 | |||||
Tangible Book Value, 2 Yr. CAGR % | 15.48 | 18.05 | 16.36 | 14.27 | 9.01 | |||||
Common Equity, 2 Yr. CAGR % | 13.11 | 15.7 | 14.59 | 13.08 | 8.21 | |||||
Cash From Operations, 2 Yr. CAGR % | -43.85 | -2.62 | -15.59 | -15.97 | 109.91 | |||||
Capital Expenditures, 2 Yr. CAGR % | 59.75 | 86.7 | 91.61 | 85.46 | -32.49 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 5.99 | 800.08 | 139.1 | 143.35 | 4.92 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 6.14 | 685.85 | 138.21 | 144.58 | 5.12 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 67.87 | 15.47 | -30.44 | -38.76 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 16.86 | 21.28 | 32.75 | 13.86 | 6.31 | |||||
Gross Profit, 3 Yr. CAGR % | 15.56 | 21.55 | 37.1 | 13.08 | 4.43 | |||||
EBITDA, 3 Yr. CAGR % | 29.44 | 34.47 | 57.75 | 9.07 | 3.3 | |||||
EBITA, 3 Yr. CAGR % | 33.67 | 40.63 | 66.33 | 8.58 | 1.33 | |||||
EBIT, 3 Yr. CAGR % | 33.97 | 41.4 | 67.44 | 8.55 | 1.19 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 27.41 | 45.71 | 61.5 | 3.86 | -5.33 | |||||
Net Income, 3 Yr. CAGR % | 27.77 | 45.16 | 60.86 | 3.57 | -5.33 | |||||
Normalized Net Income, 3 Yr. CAGR % | 35.89 | 39.64 | 67.87 | 7.62 | -1.99 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 27.51 | 45.32 | 60.85 | 3.41 | -5.31 | |||||
Accounts Receivable, 3 Yr. CAGR % | 26.35 | 60.04 | 56.25 | 33.67 | 2.96 | |||||
Inventory, 3 Yr. CAGR % | 17.94 | 41.44 | 70.86 | 45.18 | 8.25 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 5.46 | 15.32 | 32.53 | 45.27 | 34.69 | |||||
Total Assets, 3 Yr. CAGR % | 11.19 | 17.04 | 20.38 | 11.2 | 4.83 | |||||
Tangible Book Value, 3 Yr. CAGR % | 13.4 | 14.83 | 18.46 | 14.02 | 12.33 | |||||
Common Equity, 3 Yr. CAGR % | 11.37 | 12.74 | 16.21 | 12.72 | 11.14 | |||||
Cash From Operations, 3 Yr. CAGR % | 4.21 | -4.62 | 6.49 | -26.62 | 77.69 | |||||
Capital Expenditures, 3 Yr. CAGR % | 26.7 | 62.06 | 97.19 | 79.06 | 0.09 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 53.9 | -8.71 | 780.58 | 58.53 | 110.7 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 54.27 | -9.2 | 707.55 | 58.05 | 111.8 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | 53.78 | -20.63 | -21.49 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 16.9 | 14.99 | 18.57 | 19.52 | 15.63 | |||||
Gross Profit, 5 Yr. CAGR % | 26.09 | 20.67 | 18.86 | 19.27 | 15.48 | |||||
EBITDA, 5 Yr. CAGR % | 79.33 | 50.04 | 25.8 | 26 | 24.29 | |||||
EBITA, 5 Yr. CAGR % | 40.63 | 76.3 | 28.49 | 28.96 | 26.71 | |||||
EBIT, 5 Yr. CAGR % | 38.3 | 83.86 | 28.74 | 29.37 | 27.03 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 31.61 | 72.76 | 25.92 | 26.75 | 19.85 | |||||
Net Income, 5 Yr. CAGR % | 31.84 | 72.75 | 25.92 | 26.48 | 19.56 | |||||
Normalized Net Income, 5 Yr. CAGR % | 39.29 | 84.96 | 29.52 | 27.56 | 25.31 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 31.04 | 72.39 | 25.77 | 26.52 | 19.51 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.1 | 44.06 | 31.46 | 45.95 | 25.9 | |||||
Inventory, 5 Yr. CAGR % | 17.35 | 39.05 | 39.93 | 36.11 | 29.1 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -0.04 | 9 | 18.55 | 28.59 | 30.68 | |||||
Total Assets, 5 Yr. CAGR % | 11.17 | 14.68 | 13.83 | 12.59 | 11.98 | |||||
Tangible Book Value, 5 Yr. CAGR % | 12.3 | 14.7 | 14.57 | 14.6 | 14.58 | |||||
Common Equity, 5 Yr. CAGR % | 9.87 | 12.44 | 12.65 | 12.88 | 12.94 | |||||
Cash From Operations, 5 Yr. CAGR % | -18.57 | -11.75 | 31.72 | -9.33 | 39.7 | |||||
Capital Expenditures, 5 Yr. CAGR % | 27.27 | 25.28 | 49.47 | 71.04 | 28.43 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -6.68 | -29.47 | 83.5 | 34.91 | 276.01 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -6.52 | -29.66 | 83.5 | 34.74 | 257.25 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | 6.4 |
- Stock Market
- Stocks
- AIXA Stock
- Financials AIXTRON SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















